# A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma

> **NCT04780464** · PHASE3 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 14 (actual)

## Conditions studied

- Advanced Soft-tissue Sarcoma

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Doxorubicin
- **DRUG:** Cyclophosphamide Oral Product
- **DRUG:** Prednisolone
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT04780464
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-11
- **Primary completion:** 2023-09-22
- **Final completion:** 2023-11-11
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Withdrawal grant provider
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780464, "A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04780464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*